ARTICLE
|
doi:10.20944/preprints202404.0636.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
BRCA1/2 pathogenic variants; ovarian carcinoma; tumor test; next generation sequencing; real-world data
Online: 9 April 2024 (11:45:17 CEST)